Having lived with disabling chronic pain for 32 years, one reader discovered a lesser known treatment that has transformed ...

Common reasons for back pain include muscle strain, disk damage, and some chronic conditions ... Shoes with a low heel place less strain on the back. However, some flat shoes with minimal support ...

Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...

A novel biomarker signature combining PAF and CME predicts chronic pain risk, linking brain activity to individual pain ...

The greenlight for Journavx (suzetrigine), which comes on the heels of a $7.4 billion opioid settlement, could spark momentum ...

and Chronic Pain Center of Excellence for Canadian Veterans for research on pain management and perioperative care. Source Reference: Olejnik L, et al "Pharmacologic management of acute pain in ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic health condition, such as arthritis. The rising prevalence of chronic pain drives market growth by ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...

Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.